4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-043581
Chief Business Officer sold 40,000 shares at an average $14.36 ($574,200)
- Chief Business Officer acquired 40,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Virani Shafique · Chief Business Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-25 | Exercise or conversion : show line 1 in the form 10b5-1 | +20,000 | $2.22 | $44,400 | 163,954 | D |
| 2023-07-25 | Sale : show line 2 in the form 10b5-1 | −20,000 | $14.30 | $286,000 | 143,954 | D |
| 2023-07-26 | Exercise or conversion : show line 3 in the form 10b5-1 | +20,000 | $2.22 | $44,400 | 163,954 | D |
| 2023-07-26 | Sale : show line 4 in the form 10b5-1 | −20,000 | $14.41 | $288,200 | 143,954 | D |
| Open-market sales · 40,000 sh · avg $14.36 · $574,200 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-07-25 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −20,000 | $2.22 | 2030-03-03 | 20,000 | 489,469 | D |
| 2023-07-26 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −20,000 | $2.22 | 2030-03-03 | 20,000 | 469,469 | D |
Loading xslF345X05/doc4.xml…